✦ LIBER ✦

Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients

✍ Scribed by Abajo, A; Boni, V; Lopez, I; Gonzalez-Huarriz, M; Bitarte, N; Rodriguez, J; Zarate, R; Bandres, E; Garcia-Foncillas, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of serum angiopoietin-2 a

✍ Goede, V; Coutelle, O; Neuneier, J; Reinacher-Schick, A; Schnell, R; Koslowsky, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 484 KB

KRAS as prognostic biomarker in metastat

✍ Petrelli, Fausto; Coinu, Andrea; Cabiddu, Mary; Ghilardi, Mara; Barni, Sandro 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 747 KB

Prognostic Value of the Combination of C

✍ Sastre, Javier; Vidaurreta, Marta; Gómez, Auxiliadora; Rivera, Fernando; Massutí 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 686 KB

Use of a comprehensive panel of biomarke

✍ Lamas, Maria J; Duran, Goretti; Balboa, Emilia; Bernardez, Beatriz; Touris, Manu 📂 Article 📅 2011 🏛 Future Medicine 🌐 English ⚖ 701 KB

CA19-9 level as a prognostic and predict

✍ Narita, Yukiya; Taniguchi, Hiroya; Komori, Azusa; Nitta, Sohei; Yamaguchi, Kazuh 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 419 KB

6084 Efficacy and safety of bevacizumab-

✍ Ducreux, M.; Adenis, A.; Pignon, J.P.; François, E.; Chauffert, B.; Boucher, E.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB